- Home
- RCKT vs JPI Comparison
RCKT vs JPI Comparison
Compare RCKT & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- JPI
- Stock Information
- Founded
- RCKT 1999
- JPI 2012
- Country
- RCKT United States
- JPI United States
- Employees
- RCKT N/A
- JPI N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- JPI Finance Companies
- Sector
- RCKT Health Care
- JPI Finance
- Exchange
- RCKT Nasdaq
- JPI Nasdaq
- Market Cap
- RCKT 328.6M
- JPI 293.4M
- IPO Year
- RCKT N/A
- JPI N/A
- Fundamental
- Price
- RCKT $3.14
- JPI $20.41
- Analyst Decision
- RCKT Buy
- JPI
- Analyst Count
- RCKT 13
- JPI 0
- Target Price
- RCKT $14.79
- JPI N/A
- AVG Volume (30 Days)
- RCKT 3.6M
- JPI 54.7K
- Earning Date
- RCKT 08-08-2025
- JPI 01-01-0001
- Dividend Yield
- RCKT N/A
- JPI 6.15%
- EPS Growth
- RCKT N/A
- JPI N/A
- EPS
- RCKT N/A
- JPI N/A
- Revenue
- RCKT N/A
- JPI N/A
- Revenue This Year
- RCKT N/A
- JPI N/A
- Revenue Next Year
- RCKT $608.87
- JPI N/A
- P/E Ratio
- RCKT N/A
- JPI N/A
- Revenue Growth
- RCKT N/A
- JPI N/A
- 52 Week Low
- RCKT $2.19
- JPI $16.02
- 52 Week High
- RCKT $26.98
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- RCKT 49.02
- JPI 47.66
- Support Level
- RCKT $3.03
- JPI $20.20
- Resistance Level
- RCKT $3.54
- JPI $20.84
- Average True Range (ATR)
- RCKT 0.21
- JPI 0.19
- MACD
- RCKT 0.09
- JPI -0.04
- Stochastic Oscillator
- RCKT 49.37
- JPI 32.31
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.